Addiction to opioids increases the risk of several physical and psychological problems in people with multiple sclerosis (MS), a new study has found.
The study, “Impact of opium dependency on...
US researchers have found that dark rimmed spots representing ongoing, "smouldering" inflammation in the brain, called chronic active lesions, may be a hallmark of more aggressive and disabling forms...
A subtype of T-cell may restrain immune responses and be protective in multiple sclerosis (MS) according to new research titled, “Opposing T-cell responses in experimental autoimmune...
Draft guidelines issued by NICE on prescription cannabis-based medication will make it more difficult for doctors to treat MS patients with these medicines.
In the draft guidelines NICE (The National...
In a study that sought to identify common genetic variants in families with more than one member with a diagnosis of multiple sclerosis (MS), researchers from the University of British Columbia...
Scientists have discovered that a special type of cell is much more prolific in generating a protective sheath covering nerve fibres than previously believed.
The revelation about Schwann cells...
Results from Expand, a phase III study, have revealed that treatment with siponimod (Mayzent) led to significant improvement in cognitive processing speed in patients with secondary progressive...
New research conducted by the University of Edinburgh has reconfirmed that Scotland has one of the highest rates of multiple sclerosis (MS) in the world.
Using the Scottish Multiple Sclerosis...
Those with less visible disabilities are set to benefit from the biggest change in the Blue Badge scheme in 50 years. As of the 15 June 2019 new guidance on Blue Badge parking permits has been rolled...
An international team of researchers led by the University of British Columbia (UBC) has made a scientific advance they hope will lead to the development of preventative treatments for multiple...
